logo
Select company
Select metric
3.13Current Ratio
VS
Market
71
Sector
48
Industry
35
History
13
$ 11.73Close
$ 5.31 - $ 12.34 52-Week Range
Ticker Information

Ticker

RGNX

Company Name

REGENXBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

REGENXBIO INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RGNX - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 373.75M3.13$ 119.54M
3/31/2025$ 313.24M2.93$ 106.73M
12/31/2024$ 278M2.69$ 103.19M
9/30/2024$ 313.4M3.05$ 102.72M
6/30/2024$ 346.68M3.53$ 98.27M
3/31/2024$ 395.42M3.59$ 110.18M
12/31/2023$ 334.97M2.57$ 130.27M
9/30/2023$ 365.84M2.87$ 127.35M
6/30/2023$ 378.81M3.21$ 117.89M
3/31/2023$ 389.2M3.46$ 112.33M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • REGENXBIO INC's latest trailing twelve months (TTM) Current Ratio stands at 6.08.
  • Over the past 5 years, REGENXBIO INC's average Current Ratio has been 3.83.
  • The median Current Ratio for REGENXBIO INC during this period was 3.53
  • REGENXBIO INC reached its highest Current Ratio over the past 5 years at 6.52.
  • The lowest Current Ratio recorded by REGENXBIO INC in the same timeframe 2.57

REGENXBIO INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
CTMX : CYTOMX THERAPEUTICS INC 4.2XNCR : XENCOR INC 5.34ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC 5.9YMAB : Y-MABS THERAPEUTICS INC 4GLUE : MONTE ROSA THERAPEUTICS INC 7.16HRTX : HERON THERAPEUTICS INC 0.82NKTR : NEKTAR THERAPEUTICS 2.61PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC 6.92LXRX : LEXICON PHARMACEUTICALS INC 4.16VNDA : VANDA PHARMACEUTICALS INC 3.25

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for REGENXBIO INC is calculated as follows: AssetsC [ $ 386.95M ] / LiabilitesC [ $ 63.61M ]
(=) Current Ratio [ 6.08 ]

RGNX - Current Ratio, Last 5 years

2.57

Minimum

Dec 31, 2023

6.52

Maximum

Dec 31, 2020

3.83

Average

3.53

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44